Identification of a tsRNA Contributor to Impaired Diabetic Wound Healing via High Glucose-Induced Endothelial Dysfunction
Xiao-Tian Zhang,Zhen-Yang Mao,Xiang-Yun Jin,Yu-Gang Wang,Yu-Qi Dong,Chao Zhang
DOI: https://doi.org/10.2147/DMSO.S379473
2023-01-30
Abstract:Xiao-Tian Zhang, &ast Zhen-Yang Mao, &ast Xiang-Yun Jin, Yu-Gang Wang, Yu-Qi Dong, Chao Zhang Department of Orthopedics, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chao Zhang; Yu-Qi Dong, Renji Hospital, Shanghai Jiao Tong University School of Medicine, No. 160, Pujian Road, Pudong New Area, Shanghai, People's Republic of China, Tel +86-13817307997 ; +86-13331873590, Email ; Purpose: Delayed skin healing in diabetic wounds is a major clinical problem. The tRNA-derived small RNAs (tsRNAs) were reported to be associated with diabetes. However, the role of tsRNAs in diabetic wound healing is unclear. Our study was designed to explore the tsRNA expression profile and mine key potential tsRNAs and their mechanism in diabetic wounds. Methods: Skin tissues of patients with diabetic foot ulcers and healthy controls were subjected to small RNA sequencing. The role of candidate tsRNA was explored by loss- and gain-of-function experiments in HUVECs. Results: A total of 55 differentially expressed tsRNAs were identified, including 12 upregulated and 43 downregulated in the diabetes group compared with the control group. These tsRNAs were mainly concentrated in intercellular interactions and neural function regulation in GO terms and enriched in MAPK, insulin, FoxO, calcium, Ras, ErbB, Wnt, T cell receptor, and cGMP-PKG signaling pathways. tRF-Gly-CCC-039 expression was upregulated in vivo and in vitro in the diabetic model. High glucose disturbed endothelial function in HUVECs, and tRF-Gly-CCC-039 mimics further harmed HUVECs function, characterized by the suppression of proliferation, migration, tube formation, and the expression of Coll1a1, Coll4a2, and MMP9. Conversely, the tRF-Gly-CCC-039 inhibitor could attenuate high-glucose-induced endothelial injury to HUVECs. Conclusion: We investigated the tsRNAs expression profile in diabetic foot ulcers and defined the impairment role of tRF-Gly-CCC-039 in endothelial function in HUVECs. This study may provide novel insights into accelerating diabetic skin wound healing. Keywords: diabetic foot ulcers, skin healing, tsRNA expression profile, tRF-28-Q1Q89P9L84DF, endothelial damage Diabetes is an unmet clinical problem with high prevalence that was among predicted to affect 300 million patients by 2025. 1 Diabetes is a lifelong metabolic disease, which usually leads to multiple serious complications, including nephropathy, neuropathy, retinopathy, and diabetic non-healing skin ulcers. 2 Among them, diabetic non-healing skin ulcers, such as foot ulcers caused by delayed wound healing, are the most expensive and serious complications. Diabetic wounds are the most difficult to cure, which have become a major factor contributing to the health challenge and high cost for the global medical system. 3 Therefore, an accurate molecular mechanism analysis of wound healing is essential for improving the therapeutic effect of diabetic wounds. Angiogenesis, also known as neovascularization or the new blood vessels to nourish damaged tissues, is a vital step in wound healing. Impaired angiogenesis contributes to diminished wound healing in diabetic skin ulcers. 4 Therefore, the priority of enhancing wound healing in diabetic skin ulcers is to promote angiogenic responses. Vascular endothelial cells connect the entire vascular system and play a central role in angiogenesis and the wound healing. 5 Endothelial dysfunction is also the most basic and earliest pathological hallmark in diabetes. 6 However, the current treatment of diabetic skin ulcers is not only expensive but also has side effects, leading to high non-compliance and poor curative effects. Thus, the design of new therapeutic strategies targeting angiogenesis based on vascular endothelial cells may be useful for accelerating diabetic wound healing. Transfer RNA (tRNA)-derived small RNAs (tsRNAs) are an emerging regulatory class of small noncoding RNA (ncRNA). Transfer halves (tiRNA) and tRNA-derived fragments (tRFs) are the two main categories of tsRNAs, 7 which are generated from mature or precursor tRNAs by multiple cleavage of tRNAs. 8 tsRNAs can be divided into several types rest with where they map on the precursor or mature tRNA transcript. Based on tRFs' mapped positions, tRFs are roughly divided into five types: tRF-5, tRF-3, tRF-2, tRF-1, and i-tRF. 7 Although the detailed function and mechanism of tsRNAs remain elusive, some paper has shown that tsRNAs play a key role in diabetes and diabetes-related diseases. For example, Yang et al found that altered tsRNAs may play vital roles -Abstract Truncated-
endocrinology & metabolism